Skip to main content
NEUROTECH INTERNATIONAL LIMITED logo

NEUROTECH INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · NTI ISIN · AU000000NTI9 ASX Professional, scientific and technical activities
Open in API
Filings indexed 667 across all filing types
Latest filing 2019-02-24 Capital/Financing Update
Country AU Australia
Listing ASX NTI

About NEUROTECH INTERNATIONAL LIMITED

https://neurotechinternational.com/

Neurotech International Limited is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for neurodevelopmental and neurological disorders. The company specializes in neuroprotective therapies, primarily targeting pediatric conditions with significant unmet medical needs, including Autism Spectrum Disorder (ASD), Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), and Pediatric Acute-onset Neuropsychiatric Syndrome (PANS). Its lead drug candidate, NTI164, is a proprietary, broad-spectrum cannabinoid formulation derived from a unique cannabis strain. NTI164 is engineered to exert anti-inflammatory and neuroprotective effects by modulating neuroinflammatory pathways. The company conducts clinical trials to establish the safety and efficacy of its treatments, aiming to provide transformative behavioral and functional improvements for patients.

Recent filings

Filing Released Lang Actions
Appendix 3B 12 pages 444.1KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements related to these securities. It includes detailed information about the class and number of securities issued, terms of the securities, issue price, purpose of the issue, and compliance with ASX listing rules. The document does not contain financial statements or management discussion but is focused on capital raising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed issuance information, not just a brief announcement or a report publication notice.
2019-02-24 English
Neurotech secures digital marketing partner 2 pages 159.0KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Neurotech International Limited has secured a digital marketing partner as part of its new go-to-market strategy. It contains no financial data, no regulatory or shareholder meeting information, no audit or legal proceedings, and no mention of financial results or filings. The document is short (3275 characters) and is an announcement of a business partnership rather than a report or regulatory filing. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2019-02-14 English
Supplementary Prospectus 3 pages 125.3KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Supplementary Prospectus' and is dated 7 February 2019. It references a prior Prospectus dated 29 January 2019 and provides amendments and additional disclosures related to a rights issue, allocation of shortfall, director information, and expenses of the offer. The document is lodged with ASIC and ASX, indicating it is a regulatory filing related to capital raising. It is not a full prospectus but a supplementary document to it. The content focuses on amendments to the original prospectus disclosures rather than financial results or management commentary. This type of document is best classified under Capital/Financing Update (CAP) as it relates to fundraising activities and capital structure changes through a rights issue and supplementary disclosures thereto.
2019-02-06 English
Despatch of Prospectus 1 page 177.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 6 February 2019 regarding the despatch of a Prospectus and Entitlement and Acceptance Forms to eligible shareholders for a renounceable pro rata offer. It provides instructions for shareholders to participate in the offer and references the Prospectus document available on the company's website. The content is focused on informing shareholders about the capital raising process and how to participate, which aligns with updates on company fundraising activities or capital structure changes. The document is relatively short (2337 characters) and does not contain financial statements or detailed financial analysis, so it is not an Annual Report or Interim Report. It is not a report publication announcement since it does not announce the release of a report but rather the despatch of a prospectus related to a capital raising. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-02-05 English
Quarterly Report and Appendix 4C 10 pages 494.1KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly report for the period ending 31 December 2018' and contains detailed financial data including cash flow statements, operational highlights, management changes, and strategic updates. It includes substantive financial information for a quarter, not just an announcement or summary. The presence of detailed financial tables and operational commentary confirms it is a comprehensive quarterly report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q2 2019
2019-01-30 English
Despatch of Notices to Shareholders 7 pages 395.9KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 31 January 2019 regarding the despatch of notices to shareholders about a renounceable pro-rata rights issue. It includes detailed information about the rights offer, including the offer price, number of shares, timetable, eligibility criteria, and the purpose of the offer. The document is a formal announcement to shareholders about a capital raising event and the issuance of new shares and options. It does not contain financial statements or detailed financial performance data, nor is it a transcript, management report, or legal proceeding update. The content clearly relates to a capital/financing update, specifically a rights issue and shortfall offer. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2019-01-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.